The PK/PD Study of SHR0532 Tablets in Healthy Subjects

NCT03645278 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: SHR0532
DRUG: Placebo

Sponsor

Jiangsu HengRui Medicine Co., Ltd.